Advertisement

Central European Journal of Medicine

, Volume 9, Issue 5, pp 667–675 | Cite as

Predictions of cancer mortality in Poland in 2020

  • Piotr WojtyśEmail author
  • Andrzej Antczak
  • Dariusz Godlewski
Research Article
  • 41 Downloads

Abstract

Introduction

The future burden of cancer deaths will be the effect of demography changes and the influence of the risk factors. Goal. Making prognosis of number of cancer deaths in Poland in 2020.

Methodology

These predictions of number of cancer deaths in 2020 (all cancers and the most frequent cancers for men and women) has been based on the historical trends of cancer mortality in Poland in 2001–2010 and the demographical prognosis made by Central Statistical Office using the method of Hakulinen and Dyba.

Results

There will be 58 147 cancer deaths in men and 45 970 deaths in women in 2020. Compare to the period 2006–2010 the number of cancer deaths in Poland will increase by 12.0% for men and by 13.9% for women. In 2020 the big increase in number of deaths of melanoma skin cancer and multiple myeloma for both sexes, colorectal and pancreatic cancers for men and lung, endometrial and brain cancers for women will be observed.

Conclusions

The predicted increase in number of cancer deaths for Poland in 2020 will be the results of: the demographical changes, changes of the cancer risk factors, the participation in the screening programs and treatment improvement.

Keywords

Cancer Mortality Predictions Demography Risk 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Bray F, Møller B, Predicting the future burden of cancer, Nat Rev Cancer, 2006, 6, 63–74PubMedCrossRefGoogle Scholar
  2. [2]
    Tiwari RC, Ghosh K, Jemal A et al., A new method of predicting US and state-level cancer mortality counts for the current calendar year, CA Cancer J Clin, 2004, 54, 30–40PubMedCrossRefGoogle Scholar
  3. [3]
    Jemal A, Siegel R, Ward E et al., Cancer statistics, 2009, CA Cancer J Clin, 2009, 59, 225–249PubMedCrossRefGoogle Scholar
  4. [4]
    Chen HS, Portier K, Ghosh K et al., Predicting US- and state-level cancer counts for the current calendar year: part I: evaluation of temporal projection methods for mortality, Cancer, 2012, 118, 1091–1099PubMedCentralPubMedCrossRefGoogle Scholar
  5. [5]
    Malvezzi M, Arfe A, Bertuccio P et al., European cancer mortality predictions for the year 2011, Ann Oncol, 2011, 22, 947–956PubMedCrossRefGoogle Scholar
  6. [6]
    Malvezzi M, Bertuccio P, Levi F et al., European cancer mortality predictions for the year 2012, Ann Oncol, 2012, 23, 1044–1052PubMedCrossRefGoogle Scholar
  7. [7]
    Dyba T, Hakulinen T, Comparison of different approaches to incidence prediction based on simple interpolation techniques, Stat Med, 2000, 19, 1741–1752PubMedCrossRefGoogle Scholar
  8. [8]
    Hakulinen T, Dyba T, Precision of incidence predictions based on Poisson distributed Observations, Stat Med, 1994, 15, 1513–1523CrossRefGoogle Scholar
  9. [9]
    Dyba T, Hakulinen T, Paivarinta A, A simple non-linear model in incidence prediction, Stat Med, 1997, 20, 2297–2309CrossRefGoogle Scholar
  10. [10]
    Trends in Irish cancer incidence 1994–2002 with projections to 2020, National Cancer Registry, June 2006Google Scholar
  11. [11]
    Møller B, Fekjaer H, Hakulinen T et al., Prediction of cancer incidence in the Nordic countries up to the year 2020, Eur J Cancer Prev Suppl, 2002, 1, S1–S96Google Scholar
  12. [12]
    Møller H, Fairley L, Coupland V et al., The future burden of cancer in England: incidence and numbers of new patients in 2020, Br J Cancer, 2007, 96, 1484–1488PubMedCentralPubMedCrossRefGoogle Scholar
  13. [13]
    French D, Catney D, Gavin AT, Modelling predictions of cancer deaths in Northern Ireland, Ulster Med J, 2006, 75, 120–125PubMedCentralPubMedGoogle Scholar
  14. [14]
    Dyba T, Hakulinen T, Do cancer predictions work? Eur J Cancer, 2008, 44, 448–453PubMedCrossRefGoogle Scholar
  15. [15]
    Black RJ, Stockton D, Cancer Scenarios: an Aid to Planning Cancer Services in Scotland in the Next Decade, The Scottish Executive: Edinburgh, 2001Google Scholar
  16. [16]
    Parkin DM, Olsen AH, Sasieni P, The potential for prevention of colo-rectal cancer in the UK, 2009, 18, 179–190Google Scholar
  17. [17]
    Boyle P, Levin B, World Cancer Report 2008, International Agency for Research on Cancer, Lyon, 2008Google Scholar
  18. [18]
    Malvezzi M, Bertuccio P, Levi F et al., European cancer mortality predictions for the year 2013, Ann Oncol, 2013, 24, 792–800PubMedCrossRefGoogle Scholar
  19. [19]
    Bosetti C, Malvezzi M, Rosso T et al., Lung cancer mortality in European women: trends and predictions, Lung Cancer, 2012, 78, 171–178PubMedCrossRefGoogle Scholar
  20. [20]
    Bray F, Weiderpass E, Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007, Int J Cancer, 2010, 126, 1454–1466PubMedGoogle Scholar
  21. [21]
    Kelley JR, Duggan JM, Gastric cancer epidemiology and risk factors, J Clin Epidemiol, 2003, 56, 1–9PubMedCrossRefGoogle Scholar
  22. [22]
    Wojtyś P, Godlewski D, Antczak A, Predictions of cancer incidence in Poland in 2019, Central European Journal of Medicine, 2013, 8, 185–191CrossRefGoogle Scholar
  23. [23]
    Bray F, Lortet-Tieulent J, Ferlay J et al., Prostate cancer incidence and mortality trends in 37 European countries: An overview, Eur J Cancer, 2010, 46, 3040–3052PubMedCrossRefGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Piotr Wojtyś
    • 1
    Email author
  • Andrzej Antczak
    • 2
  • Dariusz Godlewski
    • 1
  1. 1.Ośrodek Profilaktyki i Epidemiologii NowotworówPoznańPoland
  2. 2.Katedra i Klinika Urologii i Onkologii UrologicznejUniwersytet MedycznyPoznańPoland

Personalised recommendations